Skanska builds healthcare center in Egersund, Norway, for NOK 320M, about SEK 310M

By Cision
Skanska

Skanska has signed a contract with Eigersund Municipality to design and build the Langevann healthcare center in Egersund, Norway. The contract is worth about NOK 320M, about SEK 310M, which will be included in the Nordic order bookings for the fourth quarter of 2026.

The approximately 8,000-square-meter healthcare center will bring together several of the municipality's health and care services. The project comprises a nursing home with 60 resident rooms, a day activity center, a production kitchen and premises for health and care services. The new center will replace parts of the existing buildings and is designed to support modern and flexible service delivery for residents, employees and visitors.

Construction is scheduled to begin in November 2026, and the project is expected to be completed in January 2029.

For further information please contact:

Audun Lågøyr, EVP Communications, Skanska Norway, tel +47 93 45 25 31

Andreas Joons, Press Officer, Skanska AB, tel +46 76 870 75 51

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com/group.

Skanska Group uses its knowledge and foresight to shape the way people live, work, and connect. We are one of the world's largest construction and project development companies, with 2025 revenue totaling SEK 179 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our approximately 25,900 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime.

https://news.cision.com/skanska/r/skanska-builds-healthcare-center-in-egersund--norway--for-nok-320m--about-sek-310m%2Cc4409784

20261016 NO healthcare center ENG

Image NO healthcare center Egersund

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.